HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 295/1/F165    most recent 90257.2008v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (3) Citing Articles via Google Scholar Google Scholar Articles by Aoki, M. Articles by Inui, K.-i. Search for Related Content PubMed PubMed Citation Articles by Aoki, M. Articles by Inui, K.-i.

Kidney-specific expression of human organic cation transporter 2 (OCT2/SLC22A2) is regulated by DNA methylation

¹Department of Pharmacy, Kyoto University Hospital, Faculty of Medicine, ²Department of Surgery, Graduate School of Medicine, and ³Department of Urology, Kyoto University Hospital, Faculty of Medicine, Kyoto University, Kyoto, Japan

Submitted 18 April 2008 ; accepted in final form 23 May 2008

Human organic cation transporter 2 (OCT2/SLC22A2), which is specifically expressed in the kidney, plays critical roles in the renal secretion of cationic compounds. Tissue expression and membrane localization of OCT2 are closely related to the tissue distribution, pharmacological effects, and/or adverse effects of its substrate drugs. However, the molecular mechanisms underlying the kidney-specific expression of OCT2 have not been elucidated. In the present study, therefore, we examined the contribution of DNA methylation of the promoter region for the OCT2 gene to its tissue-specific expression using human tissue samples. In vivo methylation status of the proximal promoter region of OCT2 and that of OCT1, a liver-specific organic cation transporter, were investigated by bisulfite sequencing using human genomic DNA extracted from the kidney and liver. All CpG sites in the OCT2 proximal promoter were hypermethylated in the liver, while hypomethylated in the kidney. On the other hand, the promoter region of OCT1 was hypermethylated in both the kidney and liver. The level of methylation of the OCT2 promoter was especially low at the CpG site in the E-box, the binding site of the basal transcription factor upstream stimulating factor (USF) 1. In vitro methylation of the OCT2 proximal promoter dramatically reduced the transcriptional activity, and an electrophoretic mobility shift assay showed that methylation at the E-box inhibited the binding of USF1. These results indicate that kidney-specific expression of human OCT2 is regulated by methylation of the proximal promoter region, interfering with the transactivation by USF1.

drug transporter; renal secretion; tissue-specific gene expression; epigenetics

This article has been cited by other articles:

				S. Imai, R. Kikuchi, H. Kusuhara, S. Yagi, K. Shiota, and Y. Sugiyama Analysis of DNA Methylation and Histone Modification Profiles of Liver-Specific Transporters Mol. Pharmacol., March 1, 2009; 75(3): 568 - 576. [Abstract] [Full Text] [PDF]

				M. Kajiwara, T. Terada, J.-i. Asaka, M. Aoki, T. Katsura, I. Ikai, and K.-i. Inui Regulation of basal core promoter activity of human organic cation transporter 1 (OCT1/SLC22A1) Am J Physiol Gastrointest Liver Physiol, December 1, 2008; 295(6): G1211 - G1216. [Abstract] [Full Text] [PDF]